↓ Skip to main content

What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation

Overview of attention for article published in AMA Journal of Ethics, September 2018
Altmetric Badge

Mentioned by

twitter
35 tweeters

Readers on

mendeley
7 Mendeley
Title
What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation
Published in
AMA Journal of Ethics, September 2018
DOI 10.1001/amajethics.2018.834
Pubmed ID
Abstract

The goal of this article is to examine the intersections of precision health and rare diseases. Specifically, we propose 3 lessons from the last decade of applying genomics to rare diseases: (1) precision can end one odyssey and start another; (2) precise interventions can exacerbate health disparities and create other ethical dilemmas; and (3) democratization of data will transform research and translation. By studying experiences of patients with rare diseases, researchers, clinicians, and policymakers can anticipate similar challenges in precision medicine and hopefully mitigate potential harms or injustices.

Twitter Demographics

The data shown below were collected from the profiles of 35 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 43%
Student > Master 1 14%
Student > Postgraduate 1 14%
Researcher 1 14%
Unspecified 1 14%
Other 0 0%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 43%
Agricultural and Biological Sciences 2 29%
Nursing and Health Professions 1 14%
Neuroscience 1 14%